Decreased cerebral spinal fluid neurotransmitter levels in Smith-Lemli-Opitz syndrome

Authors

Susan E. Sparks, National Human Genome Research Institute, Bethesda, MD
Christopher A. Wassif, National Institutes of Health, Bethesda, MD
Halima Goodwin, National Institute of Child Health and Human Development, Bethesda, MD
Sandrea K. Conley, National Institute of Child Health and Human Development, Bethesda, MD
Diane C. Lanham, Kennedy Krieger Institute, Baltimore, MD
Lisa E. Kratz, Kennedy Krieger Institute, Baltimore, MD
Kieth Hyland, Medical Neurogenetics LLC, Atlanta, GA
Andrea L. Gropman, George Washington University
and 2 additional authors...

Document Type

Journal Article

Publication Date

5-2014

Journal

Journal of Inherited Metabolic Disease

Volume

37 issue 3

Abstract

Sparks, S. E., Wassif, C. A., Goodwin, H., Conley, S. K., Lanham, D. C., Kratz, L. E., . . . Porter, F. D. (2014). Decreased cerebral spinal fluid neurotransmitter levels in smith-lemli-opitz syndrome. Journal of Inherited Metabolic Disease, 37(3), 415-420

APA Citation

Sparks, S. E., Wassif, C. A., Goodwin, H., Conley, S. K., Lanham, D. C., Kratz, L. E., Hyland, K., Gropman, A. L., & and 2 additional authors... (2014). Decreased cerebral spinal fluid neurotransmitter levels in Smith-Lemli-Opitz syndrome. Journal of Inherited Metabolic Disease, 37 issue 3 (). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_neuro_facpubs/168

Peer Reviewed

1